Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 SIGMAR1 [1] Pathways of neurodegeneration - multiple diseases D00848 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
2 SIGMAR1 [1] Pathways of neurodegeneration - multiple diseases D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
3 SIGMAR1 [1] Pathways of neurodegeneration - multiple diseases D03744 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
4 SIGMAR1 [1] Pathways of neurodegeneration - multiple diseases D11383 Blarcamesine [1] 156
5 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
6 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
7 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
8 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
9 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
10 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
11 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
12 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
13 TUBB3 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28
14 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
15 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
16 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
17 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
18 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
19 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
20 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
21 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
22 TUBB4A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28
23 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
24 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
25 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
26 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
27 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
28 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
29 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
30 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
31 TUBB4B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28
32 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00113 Atropine [2] 2, 299
33 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00138 Scopolamine [1] 2
34 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00270 Chlorpromazine [1] 254
35 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00397 Tropicamide [3] 6, 13, 19
36 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00465 Oxybutynin [3] 6, 13, 53
37 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00481 Propantheline [1] 26
38 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00722 Oxybutynin [3] 6, 13, 53
39 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00765 Rocuronium [1] 296
40 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00787 Trihexyphenidyl [2] 5, 6
41 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00789 Chlorpromazine [1] 254
42 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D01000 Bethanechol [1] 98
43 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D01077 Atropine [2] 2, 299
44 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D02069 Atropine [2] 2, 299
45 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D02212 Ipratropium [2] 6, 86
46 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D03011 Atropine [2] 2, 299
47 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D03274 Chlorpromazine [1] 254
48 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D03814 Atropine [2] 2, 299
49 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D04034 Chlorpromazine [1] 254
50 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D08441 Propiverine [1] 226
51 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D08638 Trihexyphenidyl [2] 5, 6
52 CHRM1 [3] PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D11383 Blarcamesine [1] 156
53 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00113 Atropine [2] 2, 299
54 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00138 Scopolamine [1] 2
55 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00270 Chlorpromazine [1] 254
56 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00397 Tropicamide [3] 6, 13, 19
57 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00465 Oxybutynin [3] 6, 13, 53
58 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00481 Propantheline [1] 26
59 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00525 Pilocarpine [3] 6, 53, 299
60 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00646 Tolterodine [2] 17, 53
61 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00661 Cevimeline [1] 53
62 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00722 Oxybutynin [3] 6, 13, 53
63 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00765 Rocuronium [1] 296
64 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00787 Trihexyphenidyl [2] 5, 6
65 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D00789 Chlorpromazine [1] 254
66 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D01000 Bethanechol [1] 98
67 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D01077 Atropine [2] 2, 299
68 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D01148 Tolterodine [2] 17, 53
69 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D01269 Solifenacin [3] 6, 13, 53
70 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D01699 Darifenacin [2] 6, 13
71 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D02069 Atropine [2] 2, 299
72 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D02200 Pilocarpine [3] 6, 53, 299
73 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D02212 Ipratropium [2] 6, 86
74 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D03011 Atropine [2] 2, 299
75 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D03274 Chlorpromazine [1] 254
76 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D03654 Darifenacin [2] 6, 13
77 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D03814 Atropine [2] 2, 299
78 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D04034 Chlorpromazine [1] 254
79 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D05478 Pilocarpine [3] 6, 53, 299
80 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D07226 Fesoterodine [1] 6
81 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D07667 Cevimeline [1] 53
82 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D08441 Propiverine [1] 226
83 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D08522 Solifenacin [3] 6, 13, 53
84 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D08638 Trihexyphenidyl [2] 5, 6
85 CHRM3 [4] Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pathways of neurodegeneration - multiple diseases D11383 Blarcamesine [1] 156
86 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00113 Atropine [2] 2, 299
87 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00138 Scopolamine [1] 2
88 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00270 Chlorpromazine [1] 254
89 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00397 Tropicamide [3] 6, 13, 19
90 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00465 Oxybutynin [3] 6, 13, 53
91 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00481 Propantheline [1] 26
92 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00722 Oxybutynin [3] 6, 13, 53
93 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00765 Rocuronium [1] 296
94 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00787 Trihexyphenidyl [2] 5, 6
95 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00789 Chlorpromazine [1] 254
96 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D01000 Bethanechol [1] 98
97 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D01077 Atropine [2] 2, 299
98 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D02069 Atropine [2] 2, 299
99 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D02212 Ipratropium [2] 6, 86
100 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D03011 Atropine [2] 2, 299
101 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D03274 Chlorpromazine [1] 254
102 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D03814 Atropine [2] 2, 299
103 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D04034 Chlorpromazine [1] 254
104 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D08441 Propiverine [1] 226
105 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D08638 Trihexyphenidyl [2] 5, 6
106 CHRM5 [2] Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D11383 Blarcamesine [1] 156
107 CHRNA7 [1] Pathways of neurodegeneration - multiple diseases D00765 Rocuronium [1] 296
108 CHRNA7 [1] Pathways of neurodegeneration - multiple diseases D03365 Nicotine [3] 6, 13, 84
109 CHRNA7 [1] Pathways of neurodegeneration - multiple diseases D05156 Nicotine [3] 6, 13, 84
110 CHRNA7 [1] Pathways of neurodegeneration - multiple diseases D05157 Nicotine [3] 6, 13, 84
111 MAPK14 [26] Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09639 Losmapimod [2] 113, 222
112 MAPK14 [26] Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10959 Neflamapimod [1] 8
113 CSF1 [7] Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, TNF signaling pathway, Pathways of neurodegeneration - multiple diseases, Rheumatoid arthritis D06402 Sunitinib [2] 28, 34
114 CSF1 [7] Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, TNF signaling pathway, Pathways of neurodegeneration - multiple diseases, Rheumatoid arthritis D08552 Sunitinib [2] 28, 34
115 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
116 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
117 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
118 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
119 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
120 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
121 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
122 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
123 TUBB [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28
124 MTOR [12] Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D00753 Sirolimus [41] 2, 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331
125 MTOR [12] Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D02714 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277
126 MTOR [12] Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D06068 Temsirolimus [4] 13, 34, 89, 331
127 GRIA1 [3] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D00537 Topiramate [6] 6, 97, 140, 144, 156, 193
128 GRIA1 [3] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
129 GRIA1 [3] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D02696 Talampanel [2] 2, 6
130 GRIA1 [3] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D08964 Perampanel [3] 2, 6, 144
131 GRIA2 [3] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D00537 Topiramate [6] 6, 97, 140, 144, 156, 193
132 GRIA2 [3] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
133 GRIA2 [3] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D02696 Talampanel [2] 2, 6
134 GRIA2 [3] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D08964 Perampanel [3] 2, 6, 144
135 GRIA3 [4] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Transcriptional misregulation in cancer D00537 Topiramate [6] 6, 97, 140, 144, 156, 193
136 GRIA3 [4] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Transcriptional misregulation in cancer D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
137 GRIA3 [4] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Transcriptional misregulation in cancer D02696 Talampanel [2] 2, 6
138 GRIA3 [4] Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Transcriptional misregulation in cancer D08964 Perampanel [3] 2, 6, 144
139 GRIA4 [2] Retrograde endocannabinoid signaling, Pathways of neurodegeneration - multiple diseases D00537 Topiramate [6] 6, 97, 140, 144, 156, 193
140 GRIA4 [2] Retrograde endocannabinoid signaling, Pathways of neurodegeneration - multiple diseases D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
141 GRIA4 [2] Retrograde endocannabinoid signaling, Pathways of neurodegeneration - multiple diseases D02696 Talampanel [2] 2, 6
142 GRIA4 [2] Retrograde endocannabinoid signaling, Pathways of neurodegeneration - multiple diseases D08964 Perampanel [3] 2, 6, 144
143 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00711 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
144 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
145 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00777 Amantadine [4] 6, 8, 13, 127
146 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00848 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
147 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D02780 Acamprosate [2] 6, 206
148 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
149 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D03744 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
150 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D04905 Memantine [7] 2, 6, 8, 13, 49, 127, 205
151 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07058 Acamprosate [2] 6, 206
152 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07283 Esketamine [3] 2, 4, 70
153 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07441 Amantadine [4] 6, 8, 13, 127
154 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D08098 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
155 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D08174 Memantine [7] 2, 6, 8, 13, 49, 127, 205
156 GRIN1 [5] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D09917 Latrepirdine [1] 8
157 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D00711 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
158 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
159 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D00777 Amantadine [4] 6, 8, 13, 127
160 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D00848 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
161 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D02780 Acamprosate [2] 6, 206
162 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
163 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D03744 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
164 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D04905 Memantine [7] 2, 6, 8, 13, 49, 127, 205
165 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D07058 Acamprosate [2] 6, 206
166 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D07283 Esketamine [3] 2, 4, 70
167 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D07441 Amantadine [4] 6, 8, 13, 127
168 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D08098 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
169 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D08174 Memantine [7] 2, 6, 8, 13, 49, 127, 205
170 GRIN2A [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D09917 Latrepirdine [1] 8
171 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D00711 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
172 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
173 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D00777 Amantadine [4] 6, 8, 13, 127
174 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D00848 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
175 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D02780 Acamprosate [2] 6, 206
176 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
177 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D03744 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
178 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D04905 Memantine [7] 2, 6, 8, 13, 49, 127, 205
179 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D07058 Acamprosate [2] 6, 206
180 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D07283 Esketamine [3] 2, 4, 70
181 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D07441 Amantadine [4] 6, 8, 13, 127
182 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D08098 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
183 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D08174 Memantine [7] 2, 6, 8, 13, 49, 127, 205
184 GRIN2B [6] Ras signaling pathway, Rap1 signaling pathway, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Systemic lupus erythematosus D09917 Latrepirdine [1] 8
185 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00711 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
186 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
187 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00777 Amantadine [4] 6, 8, 13, 127
188 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00848 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
189 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D02780 Acamprosate [2] 6, 206
190 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
191 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D03744 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
192 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D04905 Memantine [7] 2, 6, 8, 13, 49, 127, 205
193 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07058 Acamprosate [2] 6, 206
194 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07283 Esketamine [3] 2, 4, 70
195 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07441 Amantadine [4] 6, 8, 13, 127
196 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D08098 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
197 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D08174 Memantine [7] 2, 6, 8, 13, 49, 127, 205
198 GRIN2C [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D09917 Latrepirdine [1] 8
199 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00711 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
200 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
201 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00777 Amantadine [4] 6, 8, 13, 127
202 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D00848 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
203 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D02780 Acamprosate [2] 6, 206
204 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
205 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D03744 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
206 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D04905 Memantine [7] 2, 6, 8, 13, 49, 127, 205
207 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07058 Acamprosate [2] 6, 206
208 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07283 Esketamine [3] 2, 4, 70
209 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D07441 Amantadine [4] 6, 8, 13, 127
210 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D08098 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
211 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D08174 Memantine [7] 2, 6, 8, 13, 49, 127, 205
212 GRIN2D [3] Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D09917 Latrepirdine [1] 8
213 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
214 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
215 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
216 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
217 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
218 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
219 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
220 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
221 TUBB8 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28
222 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
223 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
224 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
225 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
226 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
227 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
228 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
229 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
230 TUBB2B [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28
231 IL1A [6] Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Pertussis, Tuberculosis, Rheumatoid arthritis D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
232 IL1A [6] Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Pertussis, Tuberculosis, Rheumatoid arthritis D06635 Rilonacept [4] 51, 106, 107, 266
233 IL1A [6] Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Pertussis, Tuberculosis, Rheumatoid arthritis D11253 Bermekimab [1] 51
234 IL1B [12] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Rheumatoid arthritis D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
235 IL1B [12] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Rheumatoid arthritis D06635 Rilonacept [4] 51, 106, 107, 266
236 IL1B [12] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Rheumatoid arthritis D09315 Canakinumab [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269
237 IL1B [12] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Rheumatoid arthritis D09911 Gevokizumab [4] 41, 50, 56, 269
238 IL6 [13] Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
239 IL6 [13] Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D08976 Pomalidomide [6] 28, 34, 51, 85, 227, 331
240 IL6 [13] Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D09669 Siltuximab [2] 28, 331
241 IL6 [13] Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis D10080 Sirukumab [2] 41, 46
242 MAPT [1] Pathways of neurodegeneration - multiple diseases D11210 Flortaucipir [3] 5, 7, 127
243 MAPT [1] Pathways of neurodegeneration - multiple diseases D11293 Gosuranemab [1] 5
244 MAP3K5 [8] Platinum drug resistance, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, Tight junction, TNF signaling pathway, Thermogenesis, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases D10988 Selonsertib [1] 86
245 NFKB1 [23] Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D01146 Iguratimod [4] 46, 51, 53, 271
246 PPP3CA [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
247 PPP3CA [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
248 PPP3CA [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D05480 Pimecrolimus [1] 160
249 PPP3CA [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
250 PPP3CA [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D09033 Voclosporin [1] 222
251 PPP3CB [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
252 PPP3CB [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
253 PPP3CB [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D05480 Pimecrolimus [1] 160
254 PPP3CB [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
255 PPP3CB [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D09033 Voclosporin [1] 222
256 PPP3CC [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
257 PPP3CC [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
258 PPP3CC [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D05480 Pimecrolimus [1] 160
259 PPP3CC [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
260 PPP3CC [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D09033 Voclosporin [1] 222
261 PPP3R1 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
262 PPP3R1 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
263 PPP3R1 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D05480 Pimecrolimus [1] 160
264 PPP3R1 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
265 PPP3R1 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D09033 Voclosporin [1] 222
266 PPP3R2 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
267 PPP3R2 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
268 PPP3R2 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D05480 Pimecrolimus [1] 160
269 PPP3R2 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
270 PPP3R2 [10] Wnt signaling pathway, VEGF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases, Tuberculosis, PD-L1 expression and PD-1 checkpoint pathway in cancer D09033 Voclosporin [1] 222
271 MAPK11 [26] Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09639 Losmapimod [2] 113, 222
272 MAPK11 [26] Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10959 Neflamapimod [1] 8
273 MAPK13 [26] Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09639 Losmapimod [2] 113, 222
274 MAPK13 [26] Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10959 Neflamapimod [1] 8
275 MAP2K1 [25] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09666 Selumetinib [1] 34
276 MAP2K1 [25] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10175 Trametinib [4] 2, 34, 279, 280
277 MAP2K1 [25] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10405 Cobimetinib [1] 280
278 MAP2K1 [25] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10604 Binimetinib [1] 34
279 MAP2K2 [22] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09666 Selumetinib [1] 34
280 MAP2K2 [22] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10175 Trametinib [4] 2, 34, 279, 280
281 MAP2K2 [22] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10405 Cobimetinib [1] 280
282 MAP2K2 [22] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10604 Binimetinib [1] 34
283 PSEN1 [2] Wnt signaling pathway, Pathways of neurodegeneration - multiple diseases D09010 Tarenflurbil [1] 13
284 PSMB5 [4] Proteasome, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D03150 Bortezomib [16] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331
285 PSMB5 [4] Proteasome, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D08880 Carfilzomib [1] 28
286 PSMB5 [4] Proteasome, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases D10130 Ixazomib [5] 13, 16, 28, 51, 61
287 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00109 Acetylsalicylic acid [15] 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251
288 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00118 Naproxen [4] 13, 46, 107, 271
289 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00120 Sulindac [1] 206
290 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00126 Ibuprofen [7] 13, 46, 65, 107, 113, 271, 299
291 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00130 Diflunisal [1] 28
292 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00132 Ketoprofen [1] 46
293 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00141 Indomethacin [3] 225, 271, 298
294 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00217 Acetaminophen [18] 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337
295 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00315 Etodolac [1] 46
296 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00330 Flurbiprofen [3] 13, 21, 46
297 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00428 Salsalate [1] 5
298 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00567 Celecoxib [10] 2, 3, 34, 46, 70, 89, 107, 161, 171, 271
299 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00568 Rofecoxib [1] 46
300 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00813 Ketorolac [2] 70, 226
301 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00903 Diclofenac [5] 13, 34, 46, 78, 271
302 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00904 Diclofenac [5] 13, 34, 46, 78, 271
303 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D00969 Meloxicam [4] 46, 49, 271, 296
304 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D01049 Nimesulide [1] 46
305 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D01122 Ibuprofen [7] 13, 46, 65, 107, 113, 271, 299
306 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D01183 Tolfenamic acid [1] 5
307 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D01475 Flurbiprofen [3] 13, 21, 46
308 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D01545 Aceclofenac [1] 46
309 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D01565 Indomethacin [3] 225, 271, 298
310 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D02110 Indomethacin [3] 225, 271, 298
311 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D02290 Flurbiprofen [3] 13, 21, 46
312 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D02709 Valdecoxib [1] 46
313 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D03710 Etoricoxib [2] 46, 271
314 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D03714 Lumiracoxib [1] 46
315 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D03716 Parecoxib [2] 46, 271
316 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D04490 Ibuprofen [7] 13, 46, 65, 107, 113, 271, 299
317 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D06606 Ibuprofen [7] 13, 46, 65, 107, 113, 271, 299
318 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D07816 Diclofenac [5] 13, 34, 46, 78, 271
319 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D08104 Ketorolac [2] 70, 226
320 PTGS2 [7] VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Small cell lung cancer D08149 Loxoprofen [2] 46, 271
321 RAF1 [22] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Tuberculosis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D06272 Sorafenib [2] 34, 86
322 RAF1 [22] Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Tuberculosis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D08524 Sorafenib [2] 34, 86
323 BCL2 [11] Platinum drug resistance, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer D10679 Venetoclax [1] 28
324 RELA [23] Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D12181 Edasalonexent [1] 113
325 MAPK12 [26] Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09639 Losmapimod [2] 113, 222
326 MAPK12 [26] Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Retrograde endocannabinoid signaling, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Relaxin signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10959 Neflamapimod [1] 8
327 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D00817 Bupropion [5] 8, 18, 21, 96, 171
328 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D01296 Methylphenidate [7] 6, 13, 34, 84, 113, 179, 206
329 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D03215 Armodafinil [3] 6, 13, 84
330 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D04999 Methylphenidate [7] 6, 13, 34, 84, 113, 179, 206
331 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D05458 Phentermine [1] 97
332 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D05459 Phentermine [1] 97
333 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D07591 Bupropion [5] 8, 18, 21, 96, 171
334 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D07938 Bupropion [5] 8, 18, 21, 96, 171
335 SLC6A3 [2] Synaptic vesicle cycle, Pathways of neurodegeneration - multiple diseases D08130 Lisdexamfetamine [1] 13
336 SNCA [1] Pathways of neurodegeneration - multiple diseases D11420 Prasinezumab [1] 6
337 SOD1 [3] Peroxisome, Prion disease, Pathways of neurodegeneration - multiple diseases D11811 Tofersen [1] 2
338 BRAF [10] Rap1 signaling pathway, Vascular smooth muscle contraction, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Pathways of neurodegeneration - multiple diseases, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D06272 Sorafenib [2] 34, 86
339 BRAF [10] Rap1 signaling pathway, Vascular smooth muscle contraction, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Pathways of neurodegeneration - multiple diseases, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D08524 Sorafenib [2] 34, 86
340 BRAF [10] Rap1 signaling pathway, Vascular smooth muscle contraction, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Pathways of neurodegeneration - multiple diseases, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10064 Dabrafenib [1] 34
341 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D00742 Etanercept [17] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298
342 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D00754 Thalidomide [20] 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331
343 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
344 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D02597 Adalimumab [18] 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271
345 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D02598 Infliximab [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271
346 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D03441 Certolizumab pegol [8] 37, 46, 49, 96, 97, 107, 226, 271
347 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D04358 Golimumab [8] 46, 56, 84, 96, 97, 107, 270, 271
348 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D04687 Lenalidomide [8] 16, 26, 28, 34, 49, 284, 300, 331
349 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D05393 Pegsunercept [1] 46
350 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D08976 Pomalidomide [6] 28, 34, 51, 85, 227, 331
351 TNF [20] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Proteoglycans in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D09944 Ozoralizumab [1] 46
352 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
353 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
354 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
355 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
356 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
357 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
358 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
359 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
360 TUBB2A [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28
361 CACNA1B [6] Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Serotonergic synapse, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D01173 Cilnidipine [1] 67
362 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00349 Isradipine [1] 6
363 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00437 Nifedipine [2] 50, 81
364 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00537 Topiramate [6] 6, 97, 140, 144, 156, 193
365 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00615 Amlodipine [4] 13, 51, 67, 298
366 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00616 Diltiazem [3] 51, 58, 86
367 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00617 Nicardipine [2] 70, 86
368 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00619 Verapamil [3] 96, 140, 167
369 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D01173 Cilnidipine [1] 67
370 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D01908 Nilvadipine [1] 90
371 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D02356 Verapamil [3] 96, 140, 167
372 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D02914 Amlodipine [4] 13, 51, 67, 298
373 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D03830 Diltiazem [3] 51, 58, 86
374 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D05442 Perhexiline [2] 58, 272
375 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D07450 Amlodipine [4] 13, 51, 67, 298
376 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D07845 Diltiazem [3] 51, 58, 86
377 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D08270 Nicardipine [2] 70, 86
378 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D08340 Perhexiline [2] 58, 272
379 CACNA1C [8] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D08441 Propiverine [1] 226
380 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00349 Isradipine [1] 6
381 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00437 Nifedipine [2] 50, 81
382 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00537 Topiramate [6] 6, 97, 140, 144, 156, 193
383 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00615 Amlodipine [4] 13, 51, 67, 298
384 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00616 Diltiazem [3] 51, 58, 86
385 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00617 Nicardipine [2] 70, 86
386 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D00619 Verapamil [3] 96, 140, 167
387 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D01173 Cilnidipine [1] 67
388 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D01908 Nilvadipine [1] 90
389 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D02356 Verapamil [3] 96, 140, 167
390 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D02914 Amlodipine [4] 13, 51, 67, 298
391 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D03830 Diltiazem [3] 51, 58, 86
392 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D05442 Perhexiline [2] 58, 272
393 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D07450 Amlodipine [4] 13, 51, 67, 298
394 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D07845 Diltiazem [3] 51, 58, 86
395 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D08270 Nicardipine [2] 70, 86
396 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D08340 Perhexiline [2] 58, 272
397 CACNA1D [8] Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Type II diabetes mellitus, Prion disease, Pathways of neurodegeneration - multiple diseases D08441 Propiverine [1] 226
398 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00349 Isradipine [1] 6
399 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00437 Nifedipine [2] 50, 81
400 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00537 Topiramate [6] 6, 97, 140, 144, 156, 193
401 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00615 Amlodipine [4] 13, 51, 67, 298
402 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00616 Diltiazem [3] 51, 58, 86
403 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00617 Nicardipine [2] 70, 86
404 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00619 Verapamil [3] 96, 140, 167
405 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D01173 Cilnidipine [1] 67
406 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D01908 Nilvadipine [1] 90
407 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D02356 Verapamil [3] 96, 140, 167
408 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D02914 Amlodipine [4] 13, 51, 67, 298
409 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D03830 Diltiazem [3] 51, 58, 86
410 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D05442 Perhexiline [2] 58, 272
411 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D07450 Amlodipine [4] 13, 51, 67, 298
412 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D07845 Diltiazem [3] 51, 58, 86
413 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D08270 Nicardipine [2] 70, 86
414 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D08340 Perhexiline [2] 58, 272
415 CACNA1F [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D08441 Propiverine [1] 226
416 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00349 Isradipine [1] 6
417 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00437 Nifedipine [2] 50, 81
418 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00537 Topiramate [6] 6, 97, 140, 144, 156, 193
419 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00615 Amlodipine [4] 13, 51, 67, 298
420 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00616 Diltiazem [3] 51, 58, 86
421 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00617 Nicardipine [2] 70, 86
422 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D00619 Verapamil [3] 96, 140, 167
423 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D01173 Cilnidipine [1] 67
424 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D01908 Nilvadipine [1] 90
425 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D02356 Verapamil [3] 96, 140, 167
426 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D02914 Amlodipine [4] 13, 51, 67, 298
427 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D03830 Diltiazem [3] 51, 58, 86
428 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D05442 Perhexiline [2] 58, 272
429 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D07450 Amlodipine [4] 13, 51, 67, 298
430 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D07845 Diltiazem [3] 51, 58, 86
431 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D08270 Nicardipine [2] 70, 86
432 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D08340 Perhexiline [2] 58, 272
433 CACNA1S [6] Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, Renin secretion, Prion disease, Pathways of neurodegeneration - multiple diseases D08441 Propiverine [1] 226
434 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
435 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
436 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
437 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
438 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
439 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
440 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
441 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
442 TUBB1 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28
443 CASP9 [11] Platinum drug resistance, PI3K-Akt signaling pathway, VEGF signaling pathway, Thyroid hormone signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer, Viral myocarditis D11195 Rimiducid [6] 19, 60, 65, 284, 285, 326
444 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00491 Paclitaxel [2] 46, 85
445 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D00570 Colchicine [7] 2, 42, 46, 56, 93, 210, 266
446 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D01068 Vinblastine [2] 34, 65
447 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D02197 Vincristine [4] 26, 34, 65, 331
448 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D05333 Paclitaxel [2] 46, 85
449 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08675 Vinblastine [2] 34, 65
450 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D08679 Vincristine [4] 26, 34, 65, 331
451 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D09587 Brentuximab vedotin [2] 49, 51
452 TUBB6 [4] Phagosome, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection D11595 Belantamab mafodotin [1] 28